Akgül Ferit, Serçelik Alper, Çetin Hakan, Erten Turgay
Bülent Ecevit University, Department of Cardiology, Zonguldak, Turkey.
Sanko University, Department of Cardiology, Gaziantep, Turkey.
PLoS One. 2017 Nov 27;12(11):e0188669. doi: 10.1371/journal.pone.0188669. eCollection 2017.
Previous reports about the relationship between a high parathyroid hormone (PTH) and low vitamin D levels with blood pressure in different hypertension groups are conflicting.
We studied serum PTH and vitamin D levels in white-coat (WCHT) and sustained hypertension (SHT) patients who had not been on antihypertensive treatment. We also investigated the association between serum PTH and vitamin D levels with respect to blood pressure in SHT and WCHT patients.
We included 52 SHT patients (54.06 ± 9.2 years, 32 newly diagnosed and 20 previously diagnosed with SHT who had not been treated with antihypertensive medication for 3 months or more), 48 WCHT patients (53.64 ± 9.5 years), and 50 normotensive (NT) healthy controls (53.44 ± 8.4 years) in our study. In addition to routine tests, PTH and vitamin D levels were measured.
Serum PTH levels were significantly higher in SHT patients not taking antihypertensive medications than in WCHT patients and NT controls (p = 0.004). Although PTH levels were higher in WCHT than in NT groups, the difference was not statistically significant. In SHT patients, PTH levels showed a positive correlation with office systolic (r = 0.363, p = 0.008), office diastolic (r = 0.282, p = 0.038), home systolic (r = 0.390, p = 0.004), and home diastolic blood pressures (r = 0.397, p = 0.003). Serum vitamin D levels were similar in SHT, WCHT and NT groups. Vitamin D levels were not associated with blood pressures in the entire study group. Furthermore, no significant relation was found between vitamin D and PTH levels in SHT and WCHT groups.
PTH levels are significantly higher in untreated SHT patients than WCHT patients and NT subjects. However, vitamin D levels are similar in SHT, WCHT and NT groups. There is a significant association between PTH levels and blood pressures suggesting PTH has a role in increase of blood pressure in SHT.
先前关于不同高血压组中高甲状旁腺激素(PTH)和低维生素D水平与血压之间关系的报道相互矛盾。
我们研究了未接受抗高血压治疗的白大衣高血压(WCHT)和持续性高血压(SHT)患者的血清PTH和维生素D水平。我们还研究了SHT和WCHT患者血清PTH和维生素D水平与血压之间的关联。
我们的研究纳入了52例SHT患者(54.06±9.2岁,32例新诊断患者和20例先前诊断为SHT且未接受抗高血压药物治疗3个月或更长时间的患者)、48例WCHT患者(53.64±9.5岁)和50例血压正常(NT)的健康对照者(53.44±8.4岁)。除常规检查外,还测量了PTH和维生素D水平。
未服用抗高血压药物的SHT患者血清PTH水平显著高于WCHT患者和NT对照组(p = 0.004)。虽然WCHT患者的PTH水平高于NT组,但差异无统计学意义。在SHT患者中,PTH水平与诊室收缩压(r = 0.363,p = 0.008)、诊室舒张压(r = 0.282,p = 0.038)、家庭收缩压(r = 0.390,p = 0.004)和家庭舒张压(r = 0.397,p = 0.003)呈正相关。SHT、WCHT和NT组的血清维生素D水平相似。维生素D水平与整个研究组的血压无关。此外,在SHT和WCHT组中,未发现维生素D与PTH水平之间存在显著关系。
未经治疗的SHT患者的PTH水平显著高于WCHT患者和NT受试者。然而,SHT、WCHT和NT组的维生素D水平相似。PTH水平与血压之间存在显著关联,提示PTH在SHT患者血压升高中起作用。